Gara Jalqabaatti › Baayyee Ulfaataa › Florida › Hialeah
Qorannoo klinikaalii Baayyee Ulfaataa Hialeah, FL keessatti
Qorannoo 10 Baayyee Ulfaataa f Hialeah fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · Miili 4 fagaatti
- fi 2 dabalataa
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Indago Research & Health Center, Inc, Miami Lakes · Miili 4 fagaatti
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Indago Research & Health Center, Inc, Miami Lakes · Miili 4 fagaatti
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Namoota walitti qabaa jiraSadarkaa 4
- NeoClinical Research, Hialeah
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Miami Lakes · Miili 4 fagaatti
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Indago Research and Health Center, Miami Lakes · Miili 4 fagaatti
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- San Marcus Research Clinic Inc, Miami Lakes · Miili 4 fagaatti
- Indago Research and Health Center, Miami Lakes · Miili 4 fagaatti
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Aga Clinical Trials, Hialeah
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 28
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Atlanta, GAQorannoo 20
- Dallas, TXQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo Hialeah keessatti
- ObesityQorannoo 13
- SchizophreniaQorannoo 13
- Cufama OnneeQorannoo 12
- Sukkaraa Gosa 2Qorannoo 10
- Dhukkubaa Harkaa SteatoticQorannoo 9
- COPDQorannoo 8
- Dhibee Gaddii GuddaaQorannoo 8
- AtherosclerosisQorannoo 8
- Dhukkubaa AlzheimerQorannoo 6
- Haala COVID Booda (COVID Dheeraa)Qorannoo 6
- Saree (Gosoota Hunda)Qorannoo 6
- Dhibee Onneessaa fi DhiigaQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.